###begin article-title 0
Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate
###end article-title 0
###begin p 1
N. Abboud and S. Desilets contributed equally to this paper.
###end p 1
###begin p 2
Embryonic stem cell pluripotency, once achieved, triggers a switch in promoter affinity for Oct4, which leads to cardiogenesis.
###end p 2
###begin p 3
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 431 436 431 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 539 544 539 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 619 624 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 629 632 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hex</italic>
###xml 52 62 <span type="species:ncbi:111938">gatekeeper</span>
###xml 263 268 <span type="species:ncbi:9606">human</span>
Oct4 exerts a dose-dependent dual action, as both a gatekeeper for stem cell pluripotency and in driving cells toward specific lineages. Here, we identify the molecular mechanism underlying this dual function. BMP2- or transgene-induced Oct4 up-regulation drives human embryonic and induced pluripotent stem cells to become cardiac progenitors. When embryonic stem cell pluripotency is achieved, Oct4 switches from the Sox2 to the Sox17 promoter. This switch allows the cells to turn off the pluripotency Oct4-Sox2 loop and to turn on the Sox17 promoter. This powerful process generates a subset of endoderm-expressing Sox17 and Hex, both regulators of paracrine signals for cardiogenesis (i.e., Wnt, BMP2) released into the medium surrounding colonies of embryonic stem cells. Our data thus reveal a novel molecular Oct4- and Sox17-mediated mechanism that disrupts the stem cell microenvironment favoring pluripotency to provide a novel paracrine endodermal environment in which cell lineage is determined and commits the cells to a cardiogenic fate.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 409 420 409 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Smith, 1991</xref>
###xml 560 576 560 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Loh et al., 2006</xref>
###xml 578 588 578 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Niwa, 2007</xref>
###xml 758 775 758 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Niwa et al., 2000</xref>
###xml 975 998 975 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Zeineddine et al., 2006</xref>
###xml 426 431 <span type="species:ncbi:10090">mouse</span>
Embryonic stem cells (ESCs), derived from the inner cell mass of the blastocyst or induced pluripotent stem cells (iPSCs) derived from reprogrammed somatic cells retain the ability to self-renew in culture and the potential to differentiate into any cell lineage. The ESC-specific protein, Oct4, is one of the most ancient transcription factors (TFs) and is expressed very early during embryonic development (Smith, 1991). In mouse ESCs, together with Sox2 and Nanog, Oct4 cooperatively maintains pluripotency through a tightly regulated transcriptional loop (Loh et al., 2006; Niwa, 2007). However, a new function of this TF has recently emerged in the process of cell lineage determination. In fact, the level of Oct4 in ESCs determines its dual function (Niwa et al., 2000). The mechanism of that process remained unknown. We demonstrated in vitro and in vivo a gene dosage-dependent function of Oct4, driving the ESC or the epiblast toward a mesodermal cardiogenic fate (Zeineddine et al., 2006).
###end p 5
###begin p 6
###xml 211 216 <span type="species:ncbi:9606">human</span>
However, the genetic and epigenetic mechanisms underlying the dual function of Oct4, maintaining pluripotency or inducing lineage progression, has remained puzzling. Furthermore, whether this concept applies to human pluripotent cells is also questionable.
###end p 6
###begin title 7
Results and discussion
###end title 7
###begin p 8
###xml 74 98 74 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Tam and Schoenwolf, 1999</xref>
###xml 225 246 225 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Tomescot et al., 2007</xref>
###xml 368 384 368 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Lee et al., 2006</xref>
###xml 580 588 580 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 665 666 665 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 682 690 682 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 750 751 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 775 778 775 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</italic>
###xml 818 819 818 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 905 929 905 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Ben-Shushan et al., 1995</xref>
###xml 1206 1211 1206 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4p</italic>
###xml 1292 1295 1292 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</italic>
###xml 1303 1311 1303 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 1385 1393 1385 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 307 312 <span type="species:ncbi:9606">human</span>
We chose the cardiac lineage, determined as early as within the epiblast (Tam and Schoenwolf, 1999), to analyze the dual function of Oct4. First, we tested whether BMP2-induced cardiac commitment and differentiation of HESC (Tomescot et al., 2007) was associated with modulation of Oct4. Expression of both human Oct4 isoforms, Oct4-iA, maintaining cell pluripotency (Lee et al., 2006), and Oct4-iB of still unknown function, was monitored by real-time quantitative PCR (RT-Q-PCR). Oct4-iA was up-regulated threefold in response to BMP2. Expression of Oct4-iB remained unchanged (Fig. 1 A). We then used a HESC line harboring a reporter gene (HUES-9 pOct4/GFP, Oct4p driving EGFP) (Fig. 1 B, inset) to investigate BMP2-mediated regulation of the Oct4p. First, to ensure that GFP was under the tight control of the Oct4p, the HUES-9 pOct4/GFP cell line was nucleofected with COUP-TFI, a repressor of Oct4 (Ben-Shushan et al., 1995). GFP was switched off in cells expressing COUP-TFI, as shown by poor GFP distribution within colonies when compared with a fully green mock colony (). Furthermore, overexpression of Oct4-iA in the HUES-9 pOct4/GFP line increased GFP expression as expected from regulation of Oct4p by its own protein (Fig. S1 B). Stimulation of this line with BMP2 up-regulated GFP mRNAs (Fig. 1 B) and FACS revealed a 70% increase in the highly positive GFP population (Fig. 1 C).
###end p 8
###begin p 9
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Overexpression of Oct4-iA induces cardiogenesis.</bold>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4</italic>
###xml 159 165 159 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">of GFP</italic>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 305 312 305 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 316 324 316 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pCMV-GFP</italic>
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 522 525 522 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hex</italic>
###xml 561 562 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Overexpression of Oct4-iA induces cardiogenesis. HUES-24 (A) or HUES-9 pOct4/GFP (B) control or treated for 48 h with BMP2. (A) Oct4 isoforms Q-PCR. (B) Q-PCR of GFP cDNA (n = 2-3). (C) GFP FACS in HUES-9 pOct4/GFP cells (top) nontreated (left) or treated (right) with BMP2. (D-F) Cells nucleofected with Oct4-iA or pCMV-GFP and cultured for 4 d. (D) FACS of GFP (inset = nucleofection efficiency) and SSEA-1 in mock cells (pcDNA backbone, left) and Oct4-iA-OEC (right). (E) Q-PCR of induced genes. (F) Q-PCR of Sox17 and Hex (amplicons on gel) (means +/- SEM [n = 3-6] normalized to huGAPDH). *, Statistically significant (P </= 0.01). (G) Immunofluorescence of anti-Sox17, -Mef2c, and -Nkx2.5 of Oct4-iA OEC scanned by an arrayscan. Bars, 20 microm. (H) Immunofluorescence of anti-sarcomeric actinin and anti-cTnT of d-30 EBs generated from mock or Oct4-iA OECs.
###end p 9
###begin p 10
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFP</italic>
###xml 220 227 220 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 266 274 266 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 322 330 322 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 416 424 416 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 505 532 505 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Hoffman and Carpenter, 2005</xref>
###xml 635 643 635 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 736 737 736 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 751 759 751 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 988 1003 988 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brachyury, Tbx6</italic>
###xml 1018 1062 1018 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mesp1/2, Tbx20, Tbx5, Mef2C, Nkx2.5, cardiac</italic>
###xml 1069 1074 1065 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">actin</italic>
###xml 1085 1093 1081 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 1113 1116 1109 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hex</italic>
###xml 1121 1126 1117 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 1161 1169 1157 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 F</xref>
###xml 1251 1259 1247 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 G</xref>
###xml 1514 1522 1510 1518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 1630 1638 1626 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 G</xref>
###xml 2289 2290 2283 2284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 2308 2309 2302 2303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2321 2322 2315 2316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2559 2567 2549 2557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 H</xref>
###xml 2832 2848 2822 2838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Liu et al., 2007</xref>
###xml 2881 2896 2871 2886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, F and G</xref>
###xml 2948 2949 2938 2939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 3097 3101 3087 3091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 3119 3136 3109 3126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Chew et al., 2005</xref>
###xml 3224 3230 3214 3220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 3291 3306 3281 3296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, A and B</xref>
###xml 3442 3447 3432 3437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 3471 3479 3461 3469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 3542 3546 3532 3536 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 3603 3609 3593 3599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 3611 3626 3601 3616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2, C and D</xref>
###xml 3797 3801 3787 3791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 3806 3811 3796 3801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 4019 4023 4009 4013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 4084 4090 4074 4080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 4122 4126 4112 4116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 4145 4151 4135 4141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 4167 4175 4157 4165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 E</xref>
###xml 4268 4276 4258 4266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 F</xref>
###xml 4372 4380 4362 4370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 G</xref>
###xml 4429 4437 4419 4427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 G</xref>
###xml 4524 4529 4514 4519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2p</italic>
###xml 4537 4543 4527 4533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 4722 4726 4712 4716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 4772 4778 4762 4768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 4839 4844 4829 4834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 5023 5029 5013 5019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 5084 5101 5074 5091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Chew et al., 2005</xref>
###xml 5146 5152 5136 5142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 5181 5189 5171 5179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 H</xref>
###xml 5292 5312 5282 5302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Mummery et al., 1991</xref>
###xml 5426 5434 5416 5424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 I</xref>
###xml 5766 5771 5756 5761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 5831 5836 5821 5826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 6096 6104 6086 6094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 6138 6143 6128 6133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 6242 6247 6232 6237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 6316 6320 6306 6310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 6440 6446 6430 6436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 6482 6490 6472 6480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 6537 6544 6527 6534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figs. 2</xref>
###xml 6549 6550 6539 6540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">3</xref>
###xml 6576 6582 6566 6572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 6851 6855 6841 6845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 7522 7528 7512 7518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 7619 7625 7609 7615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 7772 7789 7762 7779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Zorn et al., 1999</xref>
###xml 7823 7841 7813 7831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Kasai et al., 2005</xref>
###xml 7952 7959 7942 7949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 8086 8095 8076 8085 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brachyury</italic>
###xml 8097 8131 8087 8121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mesp1/2, Tbx20, Tbx5, Tbx6, Nkx2.5</italic>
###xml 8137 8156 8127 8142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cardiac &#945;-actin</italic>
###xml 8169 8176 8155 8162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 8178 8186 8164 8172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 8218 8221 8204 8207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</italic>
###xml 8380 8384 8366 8370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 8408 8414 8394 8400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 8416 8424 8402 8410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 8688 8698 8674 8684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx6 Mesp1</italic>
###xml 8700 8704 8686 8690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Isl1</italic>
###xml 8706 8712 8692 8698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.5</italic>
###xml 8714 8718 8700 8704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx5</italic>
###xml 9010 9011 8996 8997 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 9055 9056 9041 9042 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 9414 9421 9400 9407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 9607 9615 9593 9601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 9703 9725 9689 9711 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brachyury, Mesp, Tbx20</italic>
###xml 9727 9731 9713 9717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx5</italic>
###xml 9733 9737 9719 9723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx6</italic>
###xml 9739 9749 9725 9735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">and Nkx2.5</italic>
###xml 9995 9999 9981 9985 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMP2</italic>
###xml 10004 10009 9990 9995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
###xml 10011 10019 9997 10005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 10101 10102 10087 10088 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 10378 10385 10364 10371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 10911 10915 10894 10898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx6</italic>
###xml 10944 10949 10927 10932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mesp1</italic>
###xml 10977 10981 10960 10964 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx5</italic>
###xml 11373 11381 11356 11364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 E</xref>
###xml 11998 12006 11981 11989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 F</xref>
###xml 12329 12330 12300 12301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 12643 12651 12614 12622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 G</xref>
###xml 13046 13063 13017 13034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">Zorn et al., 1999</xref>
###xml 13110 13129 13081 13100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Crease et al., 1998</xref>
###xml 13131 13149 13102 13120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Kasai et al., 2005</xref>
###xml 13151 13168 13122 13139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Sumi et al., 2008</xref>
###xml 13420 13427 13388 13395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.5p</italic>
###xml 13432 13437 13400 13405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx6p</italic>
###xml 13464 13468 13432 13436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMP2</italic>
###xml 13473 13478 13441 13446 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
###xml 13560 13579 13528 13547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">M&#233;nard et al., 2004</xref>
###xml 13581 13597 13549 13565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Liu et al., 2007</xref>
###xml 13808 13826 13776 13794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Bakre et al., 2007</xref>
###xml 13828 13845 13796 13813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Sumi et al., 2008</xref>
###xml 13935 13954 13903 13922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Nostro et al., 2008</xref>
###xml 14011 14030 13979 13998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">S&#233;guin et al., 2008</xref>
###xml 14115 14133 14083 14101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">Naito et al., 2006</xref>
###xml 14190 14191 14158 14159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 14810 14811 14778 14779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 14858 14859 14826 14827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 14935 14954 14903 14922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Bondue et al., 2008</xref>
To investigate whether a rise in Oct4-iA induces loss in cell pluripotency and promotes cell lineage specification, HESCs were nucleofected with Oct4-iA, or EGFP cDNA (mock cells). Cells were cultured for 4 d with FGF2. Oct4-iA-OEC (35 times), twofold more protein (Fig. 1 E, inset), did not change expression of Oct4-iB (Fig. 1 E). Indeed, only the 48-kD (Oct4-iA), but not the 35-kD band (Oct4-iB), was increased (Fig. 1 E, inset). SSEA-1 was first used as an early marker of HESC loss of pluripotency (Hoffman and Carpenter, 2005). Less than 1% of mock cells (EGFP nucleofected) but 68% of Oct4-nucleofected cells expressed SSEA-1 (Fig. 1 D). This percentage (68%), normalized to the one of cell nucleofection assessed by scoring GFP+ cells (42%) (Fig. 1 D, inset), suggests that Oct4-iA-OEC as well as neighboring cells had entered a differentiation program. To examine which lineage was induced by Oct4, gene expression was monitored by Q-PCR. Oct4-iA-OEC expressed both mesodermal (Brachyury, Tbx6) and cardiac (Mesp1/2, Tbx20, Tbx5, Mef2C, Nkx2.5, cardiac alpha-actin) markers (Fig. 1 E). Endodermal genes Hex and Sox17 were also switched on by Oct4-iA (Fig. 1 F). Furthermore, the corresponding proteins Sox17, Nkx2.5, and Mef2c were present (Fig. 1 G). High content cell (HCC) imaging assay allowed us to monitor more than 2,500 cells and revealed that 48% of cells expressed Sox17, indicating that all nucleofected cells expressed the protein (when normalized to percentage of Oct4-iA nucleofection 42%, Fig. 1 D). Up to 20% (i,e., 48% of nucleofected cells) expressed Mef2c, and 31% (74% of nucleofected cells) Nkx2.5 (Fig. 1 G). Very low expressions of the hematopoietic CD45, of the endothelial CD31, CD34 markers were detected (Fig. S1 C). Thus, PCR, immunofluorescence, and FACS data demonstrate that up-regulation of Oct4iA forces HESC to exit pluripotency to adopt a cardiovascular fate. Furthermore, the cardiogenic action of Oct4-iA was translated into a full cardiac differentiation program. While mock-nucleofected cells gave rise to cardiomyocytes expressing actinin and cardiac troponin T (cTnT), the later proteins were not yet organized in sarcomeric units 4 wk after embryoid body (EB) formation. In contrast, EBs generated from Oct4-iA-OEC featured 3.1 +/- 0.2 (n = 4) as many cTnT+ and actinin+ myocytes as in mock EBs, as assessed by measuring the anti-cTnT and anti-actinin fluorescent areas within whole EBs. Furthermore, the cardiomyocytes were assembled in strands and featured organized and adult-size sarcomeres (2 microm) (Fig. 1 H). Next, we hypothesized that, to trigger specification to a cell lineage, increased Oct4 should disrupt the Sox2/Oct4 pluripotency loop. A potential candidate to replace Sox2 as an Oct4 target, namely Sox17, recently reported as essential for early cardiogenesis (Liu et al., 2007), was expressed in Oct4-iA-OEC (Fig. 1, F and G). We therefore tested the presence of Oct4 on Sox17p. ChIP assays designed to pull down Oct4-bound chromatin revealed that BMP2 led to a 10-fold decrease in enrichment of DNA fragments containing the Sox2 distal enhancer (Chew et al., 2005) and a 300-fold increase in the enrichment of DNA fragments containing a region of the Sox17p within the 700-bp upstream of the transcription start site (Fig. 2, A and B). This result obtained in the HUES-24 line was confirmed in two other HESC lines (H9.2 and I4). This was accompanied with induction of Sox17 in BMP2-treated cells (Fig. 2 B, right inset). Oct4-iA-OEC featured a loss in Oct4-iA binding Sox2 DNA including the distal enhancer and a gain in binding Sox17p (Fig. 2, C and D). In line with these data, ChIP from Oct4-iA-OEC using anti-modified-H3 antibodies revealed significant changes in methylation and acetylation of H3 associated with both Sox2 and Sox17 enhancer and promoter, respectively, when compared with mock cells (i.e., GFP nucleofected). Although the ratio of methylations of K4 versus that of K27 of H3, as well as acetylation of H3K9 associated with Sox2 distal enhancer was decreased, these were increased for the Sox17p. This pointed to repression of Sox2 and activation of Sox17p, respectively (Fig. 2 E). Furthermore, the Oct4/Sox2 interaction in control was lost upon up-regulation of Oct4-iA (Fig. 2 F). These transcriptional and epigenetic events led to Sox17 expression in BMP2-stimulated HESC (Fig. 2 G). A similar effect was observed in Oct4-iA-OEC (Fig. 1 G). To gain more insight into the molecular mechanism of the switch of Oct4-iA from the Sox2p to the Sox17p, we manipulated the level of expression of Sox2 in Oct4-iA-OEC, surmising that a stoichiometric competition occurs between Sox2 and Sox17. A displacement of Oct4/Sox2 complex on Sox2 distal enhancer would permit Oct4 binding to Sox17p, turning on the gene and the protein, which would reinforce Sox17 expression by forming an Oct4/Sox17 complex on its promoter. When Sox2 was up-regulated in cells nucleofected with the cDNA (Fig. S1 D), the gain in enrichment of Oct4-iA on the Sox17p was lost. When Sox2 was down-regulated using a shRNA (Chew et al., 2005) (Fig. S1, D and E), Oct4-iA binding to the Sox17p was dramatically increased (Fig. 2 H). We next looked for Oct4-Sox17 interaction in END-2 cells, an endodermal cell line expressing Sox17 (Mummery et al., 1991). Using coimmunoprecipitation after overexpression of Oct4-iA in this cell line, we found that Sox17 binds Oct4 (Fig. 2 I). Altogether, our findings point to Sox17, a novel target of Oct4 also interacting with it, to compete with Sox2 to switch HESC from a pluripotent toward an endodermal/mesodermal fate. To clarify whether Sox17 accounts for the switch of HESC from pluripotency to mesodermal and cardiac commitment of ESC, we used a shRNA approach. Sox17 ShRNA was nucleofected in HESC together with Oct4-iA cDNA. Sox17 mRNA was then reduced in the presence of an increased level of Oct4. The protein was also three times less induced by Oct4 overexpression (Fig. S1 F). The amount of Sox17 upon Oct4-iA up-regulation was thus too limited to significantly trigger cardiogenesis (Fig. 3 A). Similarly, BMP2, which induces Sox17 together with mesodermal and cardiac genes, could no longer induce these genes in the presence of Sox17 ShRNA (Fig. S1 G). However, Sox17 shRNA did not prevent the loss of Sox2 DNA elements bound to Oct4-iA when overexpressed. Interestingly, under the same condition (i.e., Sox17 silencing), the Sox17p was no longer occupied by Oct4-iA (Fig. 3 B). Thus, collectively, these ChIP experiments (Figs. 2 and 3) showed the occupancy of Sox17p by Oct4. They further revealed a predominance of K4 over K27 methylations, and an increase in K9 acetylation on H3 in the vicinity of the promoter, thus favoring an active chromatin state. This leads to gene and protein expression. The opposite scenario occurs on the Sox2 distal enhancer (loss of Oct4 occupancy of the enhancer, increase in K27 methylation, and a decrease in K9 acetylation of H3). Manipulating the levels of Sox2 and Sox17 further pointed to a competition between both Soxs as shown by the capability of Oct4 to form a complex with Sox17. We can further surmise that the Oct4/Sox2 ratio is instrumental in creating various complexes with specific Sox proteins and/or DNA elements. At a normal level of Oct4 or Oct4/Sox2 ratio, it targets the Oct4-Sox2 enhancer, maintaining the transcriptional Oct4/Sox2/Nanog loop and thus cell pluripotency. At a higher Oct4 level or at a low level of Sox2, the POU factor targets the Sox17p triggering expression of the protein, forming a more stabilized Oct4/Sox17 complex on the Sox17p. This mechanism drives the cells toward specific endo/mesodermal fates. Sox17 is known to target genes encoding cardiogenic factors such as Wnts (Zorn et al., 1999). Wnt is also a trigger of BMP2 (Kasai et al., 2005). To test whether Oct4-iA and Sox17 operate in a cell non-autonomous manner, the conditioned medium (CM) from Oct4-iA-OEC was collected to test its potential to induce cardiogenesis. CM from Oct4-iA-OEC triggers in wild-type HESC expression of Brachyury, Mesp1/2, Tbx20, Tbx5, Tbx6, Nkx2.5, and cardiac alpha-actin, as well as Oct4-iA (Fig. 4 A). CM from cells overexpressing GFP used as a control did not show any gene induction. Furthermore, CM from Oct4-iA-OEC applied to wild-type cells triggered a switch of Oct4-iA binding from the Sox2 distal enhancer to the Sox17p (Fig. 4 B). We also mixed in the same well HUES-9 pOct4/GFP cells nucleofected with Oct4-iA cDNA with mock cells at different ratios (0:1, 1:1, 3:1, 9:1, respectively). After 4 d of co-culture, mock cell colonies were dissected out and used in real-time PCR. Expression of Tbx6 Mesp1, Isl1, Nkx2.5, Tbx5 was significantly induced in mock cells when they were mixed with at least three times as many Oct4-iA-OE HUES-9 pOct4/GFP cells as mock cells (3:1 ratio) (). In another set of experiments, mixed cells were fixed and stained with an anti-Nkx2.5 antibody. These experiments showed that Nkx2.5+ cells were mainly mock HESC neighboring GFP+ cells (Fig. S2 B), further confirming that Oct4-iA-OEC exert their cardiogenic function through secretion of cardiogenic factors. We hypothesized that BMP2 or/and Wnt, both direct or indirect targets of Sox17/Hex pathway, as well as Nodal, a Sox17 inducer, might be cardiogenic candidates released by OctiA- and Sox17-OEC. Thus, HESC were nucleofected with Oct4-iA cDNA and then cultured for 4 d in the absence or in the presence of 150 ng/ml Dipkopf (DKK), 100 ng/ml Noggin, or 10 ng/ml Lefty to prevent Wnt, BMP2, or Nodal signaling, respectively. Fig. 4 C shows that both DKK and Noggin, but not Lefty, prevented Oct4-iA-induced expression of Brachyury, Mesp, Tbx20, Tbx5, Tbx6, and Nkx2.5. Challenging HESC with BMP2 (10 ng/ml) together with Wnt3a (50 ng/ml) significantly improved the effect of BMP2 on early cardiac gene expression as well as on BMP2 and Wnt3a expression (Fig. S2 C). In line with these data, Oct4-iA-OEC expressed BMP2 and Wnt3a (Fig. 4 D). Thus, BMP2 and Wnt3a are the cardiogenic factors released by Oct4 induced Sox17+ cells. Four other findings confirmed this claim. First, phosphorylated Smad recognized by an anti-phosphoSmad1,5,8 antibody was barely detectable in mock cells cultured alone, but observed into nuclei of Oct4-iA-OEC in wells including 50% (i.e., nucleofection efficiency) of Oct4-iA-OEC and 50% of non-nucleofected cells (). Second, anti-Smad4 ChIP experiments revealed a binding of Smad to both the Nkx2.5 and Tbx6 promoters, two targets of BMP2 (Fig. S3 A) in Oct4-iA-OEC. Third, Wnt3a signaling pathway was activated in Oct4-iA-OEC, as visualized by nuclear localization of beta-catenin in contrast to the membrane staining observed in mock cells (Fig. S3 B). Finally, both anti-BMP2 and anti-Wnt3a antibodies added for 2 d in the medium of Oct4-iA-OEC prevented expression of genes marking the mesoderm (Tbx6), the cardiogenic mesoderm (Mesp1), and cardiac progenitors (Tbx5) (unpublished data). To further investigate whether cells expressing Sox17 exerted their cardiogenic action through an autocrine and/or paracrine mechanism, HUES-9-pOct4/GFP cells were plated in microwells and stimulated for 4 d with BMP2. Cells expressing GFP were stained for Sox17 and Mesp1/2, the earliest cardiac marker. Cells not challenged with BMP2 did not express Sox17 or Mesp1/2 (Fig. 4 E, top). Cells challenged with BMP2 expressed both Sox17 and Mesp1/2. Careful observation of cells revealed that a few BMP2-stimulated cells expressed both Sox17 and Mesp1/2, whereas most of them expressed only Sox17 or Mesp1/2. This differential expression of Sox17 and Mesp1/2 was observed in the same or neighboring cell colonies. To further quantify the phenomenon, we set up a high-content imaging assay. 32 wells and 50 fields per well were scanned for expression of GFP, Sox17, and Mesp1/2. Cells expressing GFP, Sox17, Mesp1/2 alone or expressing two or three markers were separately scored. The Venn diagram (Fig. 4 F) first revealed that approximately50% of cells responded to BMP2, as 44% did not express Sox17 and/or Mesp1/2. Half of responder cells (33% of total) expressed Sox17 and the other half (26% of total cells) expressed Mesp1/2. The diagram clearly shows that most of the cells expressed only Sox17, with many still highly GFP+ or only Mesp2 having lost GFP. A minority of the cells expressed Sox17 and Mesp1/2; almost no cell expressed the three markers. Although 40-50% cells were nucleofected and overexpressed Oct4-iA, 40-60% also expressed several markers including Mef2c and Nkx2.5, which together confer to the cells a cardiac fate (Fig. 1 G), further pointing to a robust paracrine effect of the latter. These findings suggest that the dual function of Oct4 is mediated by a paracrine phenomenon mediated by both BMP2 and Wnt3a. This claim is supported by three series of experiments: first, inhibitors or blocking antibodies, suggesting the presence in the medium of Sox17 expressing cells of both Wnt, known to be a target of Sox17 (Zorn et al., 1999) and BMP2, which cooperates with Wnt pathway (Crease et al., 1998; Kasai et al., 2005; Sumi et al., 2008); second, the BMP2 and Wnt signaling pathways were both activated in wells containing Oct4-iA-overexpressing cells, as revealed by intranuclear localization of both p-Smad1,5,8 and beta-catenin in these cells together with the binding of Smad4 to the Nkx2.5p and Tbx6p; and third, expression of BMP2 and Wnt3a mRNAs by Oct4-OEC. Indeed, both Wnt and BMP2 are well-known cardiogenic factors (Menard et al., 2004; Liu et al., 2007). Wnt exerts a cardiogenic action early on during embryogenesis to establish the primitive streak/mesendoderm and then BMP2 together with Wnt drive the cells toward the posterior primitive streak and mesoderm (Bakre et al., 2007; Sumi et al., 2008). Furthermore, Wnt in the absence of Activin does not promote the hematopoietic lineage (Nostro et al., 2008) as well as Sox17 prevents the development of ectoderm (Seguin et al., 2008). Then, BMP2 takes over the cardiogenic task, Wnt becoming a cardiogenic inhibitor (Naito et al., 2006). The cardiogenic factors released by Oct4-induced Sox17+ cells may exert their action in an autocrine, and/or in a paracrine manner on neighboring Sox17-negative cells driving them from an undifferentiated to a mesodermal cardiogenic fate. Using HCC imaging to monitor expression of Sox17 and Mesp2 in BMP2-induced Oct4-iA-OEC revealed that one third of Oct4-iA-OEC expressed Sox17 as expected from a direct targeting of Sox17 by the POU factor, whereas many cells expressing Mesp2 did not express any longer Oct4 or Sox17. This observation argues more for a paracrine effect, although we cannot exclude a kinetic effect, cells going through a endo/mesendodermal stage (Sox17+) and then to the cardiogenic mesoderm (Mesp1/2+) turning off Sox17 in line with the inhibitory effect of Mesp1/2 on Sox17 (Bondue et al., 2008).
###end p 10
###begin p 11
###xml 0 72 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4 interaction with Sox17 promoter and protein at the expense of Sox2.</bold>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 178 182 178 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox1</italic>
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 190 195 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 282 287 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 351 358 351 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 366 370 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 484 491 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 915 920 911 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 1006 1010 1002 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 1019 1023 1015 1019 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 1053 1058 1049 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 1118 1119 1114 1115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Oct4 interaction with Sox17 promoter and protein at the expense of Sox2. Ctrl HESC or treated for 48 h with BMP2, and used for anti-Oct4 ChIP. Sox2 distal enhancer (A, pSox2) or Sox17p (B, pSox17) were amplified in RT-Q-PCR (insets = products on gel). (B, right inset) RT-Q-PCR for Sox17 in cells treated or not with BMP2. (C and D) anti-Oct4 ChIP in Oct4-iA-OECs. pSox2 or pSox17 was amplified in Q-PCR (n = 3, means +/- SEM). (E) Anti-H3trimeK4, -H3trimeK27 and -H3acetylK9 ChIP in Oct4-iA-OECs. pSoxs were amplified in Q-PCR. Results are expressed as enrichment (H3AcK9) or as a ratio of enrichment (K4/K27). Data are normalized to inputs and to controls (chromatin from GFP-nucleofected cells) from two experiments (median +/- errors). (F) Anti-Sox2 Western blots from Ctrl or Oct4-iA-OEC chromatin. (G) Immunofluorescence of anti-Sox17 and DAPI in Ctrl or BMP2-stimulated HESC. (H) Anti-Oct4 ChIP analysis of pSox17. Cells were nucleofected with GFP cDNA (Ctrl) or Oct4-iA cDNA alone or together with Sox2 cDNA or Sox2 ShRNA before ChIP. Q-PCR of pSox17 (gel of amplicons on the left). The enrichment in ShRNASox2+ Oct4-OEC was normalized to the one of Oct4-iA-OECs (set to 1). Results are expressed as the median +/- errors from two experiments. (I) END-2 cells expressing Sox17 were nucleofected with Oct4-iA and cultured for 2 d. Immunoprecipitation of anti-Oct4 and Western blot of anti-Sox17. END-2 whole-cell lysate was run as a positive control.
###end p 11
###begin p 12
###xml 0 61 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17 mediates Oct4-triggered cardiogenic commitment of HESC.</bold>
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 154 155 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 223 229 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Sox17 mediates Oct4-triggered cardiogenic commitment of HESC.Oct4-iA cDNA alone or together with Sox17 ShRNA was nucleofected in HESC (A) Q-PCR of genes (n = 3). (B) Anti-Oct4ChIP-Q-PCR analysis of Sox2 distal enhancer and Sox17p (n = 3, mean +/- SEM).
###end p 12
###begin p 13
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Overexpression of Oct4-iA induces secretion of paracrine factors.</bold>
###xml 86 87 86 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 152 158 152 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 334 341 334 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 345 348 345 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GFP</italic>
###xml 449 453 449 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMP2</italic>
###xml 458 463 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
Overexpression of Oct4-iA induces secretion of paracrine factors. (A) Q-PCR of genes (n = 3-5). (B) Anti-Oct4 ChIP analysis of Sox2 distal enhancer and Sox17p (pSox) in wild-type HESC treated for 4 d with CM of Oct4-iA-OEC. CM from GFP-nucleofected mock cells was used as control (experiment in duplicate). (C) HESC nucleofected with Oct4-iA or GFP (mock cells) and cultured for 4 d in the absence or presence of DKK, Noggin, or Lefty. (D) Q-PCR of BMP2 and Wnt3a in Oct4iA-OEC. (E) anti-Sox17 and -Mesp2 immunofluorescence of Ctrl and BMP2-treated HUES-9 pOct4/GFP cells. (F) Venn diagram for the number of cells positive for GFP, Sox17, and Mesp2 alone or together. Ctrl or BMP2-challenged HUES-9 pOct4/GFP cells in 96-well plates were stained with anti-Sox17 and -Mesp2 antibodies. Numbers in the diagram indicate the total number of cells and the percentage. *, Significantly different from control (P </= 0.001).
###end p 13
###begin p 14
###xml 356 378 356 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Takahashi et al., 2007</xref>
###xml 560 567 560 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 602 608 602 608 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 720 727 720 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA</italic>
###xml 957 966 957 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brachyury</italic>
###xml 968 975 968 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mesp1/2</italic>
###xml 977 982 977 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx20</italic>
###xml 984 988 984 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Tbx5</italic>
###xml 994 1000 994 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx2.5</italic>
###xml 1013 1018 1013 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 1058 1062 1058 1062 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox2</italic>
###xml 1070 1076 1070 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17p</italic>
###xml 1132 1137 1132 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sox17</italic>
###xml 1169 1174 1169 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Wnt3a</italic>
###xml 1179 1183 1179 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BMP2</italic>
Our data thus revealed a novel Oct4/Sox17-mediated molecular mechanism that disrupts the microenvironment that favors cell pluripotency and prevents differentiation, to provide a novel paracrine environment more prone to commit the cells toward a cardiac lineage. iPSC are derived from somatic cells reprogrammed using Oct4, Sox2, Nanog, and Lin28 or Myc (Takahashi et al., 2007). We wondered whether manipulating the Oct4-iA level in such cells could also drive them through the Sox2/Sox17 switch toward a cardiogenic fate. Thus, iPSCs were nucleofected with Oct4-iA cDNA and both gene expression and Sox17p occupancy were monitored by Q-PCR. Fig. S3 C shows that 5 d after nucleofection, iPSC expressing 10 times more Oct4-iA mRNA than GFP nucleofected cells changed of morphology, displaying more flat and irregular colonies in comparison with compact colonies in mock cells expressing GFP. These cells expressed mesodermal and cardiac markers including Brachyury, Mesp1/2, Tbx20, Tbx5, and Nkx2.5, as well as Sox17 (Fig. S3 D). Oct4-iA switched from the Sox2 to the Sox17p (Fig. S3 E). This was associated with up-regulation of Sox17 (Fig. S3 D, inset) and of both Wnt3a and BMP2 mRNAs (Fig. S3 F).
###end p 14
###begin p 15
###xml 517 537 517 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Peerani et al., 2007</xref>
###xml 570 571 570 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 746 752 746 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5</xref>
###xml 112 117 <span type="species:ncbi:9606">human</span>
Thus, we have found a novel molecular and cellular circuit in which Oct4 and Sox17 work in combination to drive human pluripotent stem cells toward an endodermal or mesendodermal fate, and in turn toward the fate of cardiac progenitors. This circuit is functional within an ESC colony or "niche", BMP2 acting first in cells surrounding the colony, likely generating a gradient from the outer to the inner part of colonies rather secreting factors such as GDF3 maintaining a basal level of Oct4 and cell pluripotency (Peerani et al., 2007). Then, mesendo/endodermal Sox17+ cells amplify the differentiation process by secreting cardiogenic factors (i.e., Wnt3a, BMP2), further acting on the colonies to direct the cells toward a cardiogenic fate (Fig. 5). This molecular and cellular circuitry is likely to occur during the process of somatic cell reprogramming using Oct4 as the main reprogramming inducer, pointing to the importance of an accurate Oct4/Sox2 dosage in these experiments. Oct4 dosage within the nucleus is thus crucial to build specific bridges between different (i.e., Sox2 or Sox17) chromatin domains, resulting in generation of "transcription factories" working either to maintain ES cell pluripotency or to drive them toward a cardiogenic fate.
###end p 15
###begin p 16
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The Sox17/Oct4 circuit is functional within a stem cell colony or &#8220;niche&#8221;.</bold>
The Sox17/Oct4 circuit is functional within a stem cell colony or "niche". Oct4 and Sox17 work in combination to drive HuPSC toward a mesendodermal fate, and through secretion of BMP2 and wnt3a toward the fate of cardiac progenitors.
###end p 16
###begin title 17
Materials and methods
###end title 17
###begin title 18
###xml 34 39 <span type="species:ncbi:9606">human</span>
Culture and cardiac commitment of human pluripotent stem cells
###end title 18
###begin p 19
###xml 38 59 38 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Maherali et al., 2008</xref>
###xml 445 465 445 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Tomescot et al. 2007</xref>
###xml 68 73 <span type="species:ncbi:9606">human</span>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
###xml 406 411 <span type="species:ncbi:10090">mouse</span>
Two HESC lines and one HiPSC line 11 (Maherali et al., 2008), using human dermal fibroblasts infected by lentivirus harboring the cDNAs encoding Oct4, Sox2, Lin 28, Klf4, and Nanog, were used throughout this study without any difference in results. HUES-24 and HUES-9 pOct4/GFP (a transgenic cell line generated using BAC) and iPS cell were cultured on mouse embryonic fibroblasts (MEFs) prepared from E14 mouse embryos as described previously (Tomescot et al. 2007). HESC were treated for 48 h with 10 ng/ml BMP2 in the presence of 1 microM SU5402, an FGF receptor inhibitor, in KOSR-DMEM. HESC (both HUES-9 and HUES-24) were used within no more than 10 passages (P28-P38). Cells are phenotyped every 10 passages using anti-SSEA-3/4, TRA-1-60, and TRA-1-80 antibodies (Millipore). Less than 5% of cells were positive for SSEA-1 (Millipore). Karyotype was found normal and stable in the course of the experiments. EBs were generated from mock (GFP)-nucleofected or Oct4-iA-nucleofected in DMEM added with 20% FCS. Cells were let in suspension for 5 d to allow for their aggregation and then EBs were plated on gelatin-coated dishes for the next 3 wks. The blocking anti-BMP2 and anti-Wnt3a antibodies (MAB3552 and MAB1324, respectively; R&D Systems), used at a concentration of 7.5 microg/ml medium, were added to mock or Oct4-iA-nucleofected cells for 2 d before RNA extraction and RT-Q-PCR of Tbx6, Mesp1, and Tbx5 genes.
###end p 19
###begin title 20
RT-Q-PCR by SYBR green detection
###end title 20
###begin p 21
###xml 529 542 525 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Pfaffl (2001)</xref>
###xml 594 616 590 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Tomescot et al. (2007)</xref>
###xml 565 570 <span type="species:ncbi:9606">human</span>
RNA was extracted from ES cells using a QIAGEN or Zymo Research (Proteingene) kit or a Zymo Research RNA MicroPrep (Proteingene) for singles colonies. 1 microg of RNA was reverse-transcribed using the SuperScriptII reverse transcription (Invitrogen) and oligo(16)dT. Q-PCR was performed using a Light Cycler LC 1.5 or 480 (Roche) according to the manufacturer. Melting curves were used to determine the specificity of PCR products, confirmed using conventional gel electrophoresis and sequencing. Data were analyzed according to Pfaffl (2001). Primers specific for human genes are described in Tomescot et al. (2007) and are available on request.
###end p 21
###begin p 22
Primers to amplify enhancer/promoter regions were: Sox17 promoter: forward, 5'-actttcacagtccaggaacggagt-3' and reverse 5'-ggcttccttggagaaaggcaat-3' targeting a region within the 700-bp region upstream the transcription start site; Sox2: distal enhancer forward, 5'-attagtctgctcttcctcggaatggttgg-3' and reverse, 5'-tgatgcttgttaaaaacgcttcgctcc-3'. Nkx2.5 promoter: forward 5'-cagtcttgggagctcaagact-3' and reverse 5'-cagatccccaagcttactagc-3'; Tbx6 promoter: forward 5'-taacccgttcctgccccacct-3' and reverse 5'-tccgcttgagctcccccttcc-3'.
###end p 22
###begin title 23
Chromatin immunoprecipitation (ChIP) assay
###end title 23
###begin p 24
###xml 41 62 41 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Dahl and Collas, 2007</xref>
###xml 87 106 87 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Nelson et al., 2006</xref>
###xml 191 214 191 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Zeineddine et al., 2006</xref>
###xml 541 562 541 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Dahl and Collas, 2007</xref>
ChIP was performed according the Q2ChIP (Dahl and Collas, 2007) or Fast ChIP protocol (Nelson et al., 2006). Data were also confirmed using a standard ChIP procedure as described previously (Zeineddine et al., 2006). The antibodies used were anti-Oct4 (Santa Cruz Biotechnology, Inc.), anti-Smad4 (Santa Cruz Biotechnology, Inc.) and anti-H3triMeK4, triMeK27, and acetylK9 (UBI). Q-PCR was used to amplify the DNA elements as described above. Absolute enrichment was calculated assuming that at most 1% of nucleosome was immunoprecipitated (Dahl and Collas, 2007). Genomic region was thus considered enriched if 10-ng immunoprecipitation samples showed a greater enrichment when compared with 0.1 ng of input DNA. Data in all the text and figures are normalized to a control condition (absolute enrichment set to one) and are thus representative of a relative enrichment in one experimental condition (BMP2 treatment or Oct4 up-regulation) versus the control (non-treated cells or mock cells).
###end p 24
###begin title 25
DNA constructs
###end title 25
###begin p 26
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Sox17 ShRNA targeted the following Sox17 cDNA sequence: 5'-gcaggtgaagcggctgaag-3'. This was synthesized as a sense and antisense oligonucleotide, annealed and subcloned in pSuper vector (Ambion). The DNA constructs were nucleofected in HESCs, using Amaxa specific nucleofector solution I, as recommended by the manufacturer.
###end p 26
###begin p 27
###xml 67 84 67 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Lee et al. (2006)</xref>
Oct4-iA was amplified from RNA extracted from HESC as described in Lee et al. (2006) and subcloned in a pcDNA vector.
###end p 27
###begin title 28
Cell immunofluorescence and imaging
###end title 28
###begin p 29
###xml 63 86 63 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Zeineddine et al., 2006</xref>
Cell immunofluorescence was performed as described previously (Zeineddine et al., 2006). The anti-Sox17 antibody was from R&D Systems (Mab1924); anti-Nkx2.5 antibody from R&D Systems (MAB2444 clone 259416); anti-Mef2c from Aviva; anti-CD31, CD45, and CD34 from Becton Dickinson; anti-phospho-Smad1/5/8 from Cell Signaling Technology; anti-beta-catenin from BD Biosciences; anti-sarcomeric actinin from Sigma-Aldrich; and anti-cTnt from Abcam. Slides were mounted using Fluoromount-G (Electron Microscopy Science).
###end p 29
###begin p 30
Cardiac TnT and alpha-actinin fluorescent areas were measured in EBs using a thresholding and setting the cTnT and alpha-actinin fluorescent areas as regions of interest (ROI) within whole EBs observed at 4x to measure the number of pixels within these ROIs with ImageJ software (National Institutes of Health, Bethesda, MD).
###end p 30
###begin p 31
###xml 151 159 151 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 251 259 251 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 G</xref>
###xml 404 412 404 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 H</xref>
###xml 500 506 500 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
Images were acquired at room temperature with an epifluorescence microscope (AxioImager; Carl Zeiss, Inc.) using an Achroplan 10x objective (NA 0.25) (Fig. 1 C), a microscope (Axiostar; Carl Zeiss, Inc.) using an N-Achroplan objective (20x, NA 0.45) (Fig. 1 G), or a laser-scanning microscope (LSM510 Meta; Carl Zeiss, Inc.) using an Achroplan objective 10x (NA 0.25) and Fluar 40x oil (NA 1.3) zoom 2x (Fig. 1 H), and visualized without any processing by LSM browser software (Carl Zeiss, Inc.) or (Fig. 2) a microscope (Multiphoton Radiance 2000MP; Bio-Rad Laboratories) attached to a Nikon Eclipse with a 10x PL-APO (NA 0.45) at room temperature and visualized with Bio-Rad Laboratories software and ImageJ without any processing.
###end p 31
###begin title 32
FACS analysis
###end title 32
###begin p 33
HESC were trypsinized and washed twice with PBS, filtered through a 70-microm mesh filter before FACS analysis using FACS Calibur (Becton Dickinson) and CELL QUEST software.
###end p 33
###begin title 34
Protein immunoprecipitation and Western blots
###end title 34
###begin p 35
###xml 278 297 278 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Puc&#233;at et al., 1998</xref>
END-2 cells were cultured in DMEM, supplemented with 10% FCS. Cells were nucleofected with Oct4-iA cDNA using the kit V (Amaxa). Cells were lysed in RIPA buffer. Co-Immunoprecipitation was performed in RIPA buffer and Western blot analysis was conducted as reported previously (Puceat et al., 1998). The anti-Oct4 antibodies used were from Santa Cruz Biotechnology, Inc. Sox2 and Oct4 Western blots were performed using the anti-Sox2 from Santa Cruz Biotechnology, Inc., and anti-Oct4 recognizing both Oct4-iA and -iB.
###end p 35
###begin title 36
Screening of immunostained cells by high content imaging
###end title 36
###begin p 37
###xml 139 144 <span type="species:ncbi:10090">mouse</span>
###xml 198 204 <span type="species:ncbi:9986">rabbit</span>
###xml 270 276 <span type="species:ncbi:9986">rabbit</span>
###xml 341 346 <span type="species:ncbi:10090">mouse</span>
Immunofluorescence scan of BMP2-treated HUES-9 pOct4/GFP or Oct4iA nucleofected HESC stained with anti-Sox17 and Alexa 546-conjugated anti-mouse IgG or anti-Mesp2 and anti-Alexa 680-conjugated anti-rabbit IgG antibodies or anti-Nkx2.5 and anti-Alexa 488-conjugated anti-rabbit IgG antibodies or anti-Mef2c and anti-Alexa 488-conjugated anti-mouse IgG antibodies: HESC were plated in 96-wells plates on MEF and treated or not with 10 ng/ml BMP2 and SU5402 for 4 d. Other cells were nucleofected with Oct4iA cDNA and plated in Labtech. After immunostaining, the HC imaging 96-well plates (cells in PBS) were scanned with the Arrayscan (Cellomics Thermo Fisher Scientific attached to an inverted microscope [Carl Zeiss, Inc.] and using 20x N-Achroplan objective, NA 0.45, at room temperature) using the Cell Health Profiling Bioapplication. The fluorescence threshold was determined from the background obtained in non-BMP2-stimulated cells or mock cells and set as a fixed threshold value to scan the wells of BMP2-treated cells or Oct4iA-nucleofected cells. In BMP2 experiments, 50 fields/well and 32 wells were scanned giving a total of 98,120 cells selected according the morphology, size, and the proximity of their nuclei (i.e., to discriminate HESC colonies from feeder cells). Different types of events were scored using the cell feature parameters and the Boolean operators. The visualization of images and analysis were then performed using the vHCS software.
###end p 37
###begin title 38
Online supplemental material
###end title 38
###begin p 39
Fig. S1: characterization of HUES-9 pOct4/GFP clone. Non-cardiac potential of differentiation of Oct4-OEC. KO of Sox2/Sox17 and consequences on BMP2-induced gene expression. Fig. S2: paracrine action of Oct4-overexpressing cells. Fig. S3: Oct4-overexpressing cells activate Smad and beta-catenin pathways; The Oct4/Sox17 network is conserved in iPSCs. Online supplemental material is available at .
###end p 39
###begin title 40
Supplementary Material
###end title 40
###begin title 41
[Supplemental Material]
###end title 41
###begin p 42
###xml 272 276 <span type="species:ncbi:162683">Mayo</span>
We thank Dr. H.H. Ng (Genome Institute of Singapore) for the gift of Sox2 ShRNA plasmid; Drs. M. Mitjavila and N. Lefort for help in FACS analysis; Y. Maury (INSERM-UMR861) for help in HC imaging; O. Guillevic, L. Hamon, and G. Blin for experimental help; Drs. A. Terzic (Mayo Foundation, Rochester, MN), H.H. Ng (Biopolis Singapore), and R. Feil (CNRS Montpellier, France) for critical reading of the manuscript; and Dr. M. Buckingham (Pasteur Institute, Paris) for her invaluable comments on the manuscript.
###end p 42
###begin p 43
We thank the National Agency for Research (ANR, programmes Blanc, HUES signature and Specistem) and Genopole for funding this research. S. Stefanovic and D. Nury were funded by ANR.
###end p 43
###begin article-title 44
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation.
###end article-title 44
###begin article-title 45
A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct-3/4 expression in embryonal carcinoma cells.
###end article-title 45
###begin article-title 46
Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification.
###end article-title 46
###begin article-title 47
Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells.
###end article-title 47
###begin article-title 48
Cooperation between the activin and Wnt pathways in the spatial control of organizer gene expression.
###end article-title 48
###begin article-title 49
###xml 137 142 <span type="species:ncbi:9606">human</span>
Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells.
###end article-title 49
###begin article-title 50
###xml 32 37 <span type="species:ncbi:9606">human</span>
Characterization and culture of human embryonic stem cells.
###end article-title 50
###begin article-title 51
Wnt signaling regulates the sequential onset of neurogenesis and gliogenesis via induction of BMPs.
###end article-title 51
###begin article-title 52
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human OCT-4 isoforms differ in their ability to confer self-renewal.
###end article-title 52
###begin article-title 53
Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cells.
###end article-title 53
###begin article-title 54
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells.
###end article-title 54
###begin article-title 55
###xml 57 62 <span type="species:ncbi:9606">human</span>
A high-efficiency system for the generation and study of human induced pluripotent stem cells.
###end article-title 55
###begin article-title 56
Cardiac specification of embryonic stem cells.
###end article-title 56
###begin article-title 57
###xml 60 66 <span type="species:ncbi:10090">murine</span>
Visceral-endoderm-like cell lines induce differentiation of murine P19 embryonal carcinoma cells.
###end article-title 57
###begin article-title 58
Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis.
###end article-title 58
###begin article-title 59
Protocol for the fast chromatin immunoprecipitation (ChIP) method.
###end article-title 59
###begin article-title 60
How is pluripotency determined and maintained?
###end article-title 60
###begin article-title 61
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells.
###end article-title 61
###begin article-title 62
Wnt, activin, and BMP signaling regulate distinct stages in the developmental pathway from embryonic stem cells to blood.
###end article-title 62
###begin article-title 63
###xml 26 31 <span type="species:ncbi:9606">human</span>
Niche-mediated control of human embryonic stem cell self-renewal and differentiation.
###end article-title 63
###begin article-title 64
A new mathematical model for relative quantification in real-time RT-PCR.
###end article-title 64
###begin article-title 65
Src family tyrosine kinase regulates intracellular pH in cardiomyocytes.
###end article-title 65
###begin article-title 66
###xml 80 85 <span type="species:ncbi:9606">human</span>
Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells.
###end article-title 66
###begin article-title 67
Culture and differentiation of embryonic stem cells.
###end article-title 67
###begin article-title 68
###xml 40 45 <span type="species:ncbi:9606">human</span>
Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, activin/nodal and BMP signaling.
###end article-title 68
###begin article-title 69
###xml 47 52 <span type="species:ncbi:9606">human</span>
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
###end article-title 69
###begin article-title 70
Cardiac fate map: lineage, allocation, morphogenetic movement and cell commitment.
###end article-title 70
###begin article-title 71
Heart Development.
###end article-title 71
###begin article-title 72
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 100 104 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
Differentiation in vivo of cardiac committed human embryonic stem cells in postmyocardial infarcted rats.
###end article-title 72
###begin article-title 73
Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development.
###end article-title 73
###begin article-title 74
Regulation of Wnt signaling by Sox proteins: XSox17 alpha/beta and XSox3 physically interact with beta-catenin.
###end article-title 74
###begin p 75
###xml 0 33 0 33 <title xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="76">Abbreviations used in this paper:</title>
###xml 33 35 33 35 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CM</term>
###xml 35 53 35 53 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="77">conditioned medium</p>
###xml 35 53 35 53 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="77">conditioned medium</p></def>
###xml 33 53 33 53 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>CM</term><def><p textid="77">conditioned medium</p></def></def-item>
###xml 53 57 53 57 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cTnT</term>
###xml 57 75 57 75 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="78">cardiac troponin T</p>
###xml 57 75 57 75 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="78">cardiac troponin T</p></def>
###xml 53 75 53 75 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>cTnT</term><def><p textid="78">cardiac troponin T</p></def></def-item>
###xml 75 77 75 77 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EB</term>
###xml 77 90 77 90 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="79">embryoid body</p>
###xml 77 90 77 90 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="79">embryoid body</p></def>
###xml 75 90 75 90 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>EB</term><def><p textid="79">embryoid body</p></def></def-item>
###xml 90 93 90 93 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ESC</term>
###xml 93 112 93 112 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="80">embryonic stem cell</p>
###xml 93 112 93 112 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="80">embryonic stem cell</p></def>
###xml 90 112 90 112 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>ESC</term><def><p textid="80">embryonic stem cell</p></def></def-item>
###xml 112 115 112 115 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HCC</term>
###xml 115 132 115 132 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="81">high content cell</p>
###xml 115 132 115 132 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="81">high content cell</p></def>
###xml 112 132 112 132 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>HCC</term><def><p textid="81">high content cell</p></def></def-item>
###xml 132 136 132 136 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HESC</term>
###xml 136 145 136 145 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="82">human ESC</p>
###xml 136 145 136 145 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="82">human ESC</p></def>
###xml 132 145 132 145 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>HESC</term><def><p textid="82">human ESC</p></def></def-item>
###xml 145 149 145 149 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">iPSC</term>
###xml 149 178 149 178 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="83">induced pluripotent stem cell</p>
###xml 149 178 149 178 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="83">induced pluripotent stem cell</p></def>
###xml 145 178 145 178 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>iPSC</term><def><p textid="83">induced pluripotent stem cell</p></def></def-item>
###xml 178 189 178 189 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Oct4-iA-OEC</term>
###xml 189 217 189 217 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="84">Oct4-iA&#8211;overexpressing cells</p>
###xml 189 217 189 217 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="84">Oct4-iA&#8211;overexpressing cells</p></def>
###xml 178 217 178 217 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>Oct4-iA-OEC</term><def><p textid="84">Oct4-iA&#8211;overexpressing cells</p></def></def-item>
###xml 217 218 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 217 218 217 218 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><italic>p</italic></term>
###xml 218 226 218 226 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="85">promoter</p>
###xml 218 226 218 226 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="85">promoter</p></def>
###xml 217 226 217 226 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term><italic>p</italic></term><def><p textid="85">promoter</p></def></def-item>
###xml 226 234 226 234 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT-Q-PCR</term>
###xml 234 260 234 260 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="86">real-time quantitative PCR</p>
###xml 234 260 234 260 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="86">real-time quantitative PCR</p></def>
###xml 226 260 226 260 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>RT-Q-PCR</term><def><p textid="86">real-time quantitative PCR</p></def></def-item>
###xml 260 262 260 262 <term xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TF</term>
###xml 262 282 262 282 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="87">transcription factor</p>
###xml 262 282 262 282 <def xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="87">transcription factor</p></def>
###xml 260 282 260 282 <def-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><term>TF</term><def><p textid="87">transcription factor</p></def></def-item>
###xml 0 282 0 282 <def-list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><title textid="76">Abbreviations used in this paper:</title><def-item><term>CM</term><def><p textid="77">conditioned medium</p></def></def-item><def-item><term>cTnT</term><def><p textid="78">cardiac troponin T</p></def></def-item><def-item><term>EB</term><def><p textid="79">embryoid body</p></def></def-item><def-item><term>ESC</term><def><p textid="80">embryonic stem cell</p></def></def-item><def-item><term>HCC</term><def><p textid="81">high content cell</p></def></def-item><def-item><term>HESC</term><def><p textid="82">human ESC</p></def></def-item><def-item><term>iPSC</term><def><p textid="83">induced pluripotent stem cell</p></def></def-item><def-item><term>Oct4-iA-OEC</term><def><p textid="84">Oct4-iA&#8211;overexpressing cells</p></def></def-item><def-item><term><italic>p</italic></term><def><p textid="85">promoter</p></def></def-item><def-item><term>RT-Q-PCR</term><def><p textid="86">real-time quantitative PCR</p></def></def-item><def-item><term>TF</term><def><p textid="87">transcription factor</p></def></def-item></def-list>
Abbreviations used in this paper:CMconditioned mediumcTnTcardiac troponin TEBembryoid bodyESCembryonic stem cellHCChigh content cellHESChuman ESCiPSCinduced pluripotent stem cellOct4-iA-OECOct4-iA-overexpressing cellsppromoterRT-Q-PCRreal-time quantitative PCRTFtranscription factor.
###end p 75
###begin title 76
Abbreviations used in this paper:
###end title 76
###begin p 77
conditioned medium
###end p 77
###begin p 78
cardiac troponin T
###end p 78
###begin p 79
embryoid body
###end p 79
###begin p 80
embryonic stem cell
###end p 80
###begin p 81
high content cell
###end p 81
###begin p 82
###xml 0 5 <span type="species:ncbi:9606">human</span>
human ESC
###end p 82
###begin p 83
induced pluripotent stem cell
###end p 83
###begin p 84
Oct4-iA-overexpressing cells
###end p 84
###begin p 85
promoter
###end p 85
###begin p 86
real-time quantitative PCR
###end p 86
###begin p 87
transcription factor
###end p 87

